Skip to main content
Log in

Thrombomodulin in systemic lupus erythematosus: association with clinical and laboratory parameters

  • ORIGINAL ARTICLE
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Thrombomodulin is an endothelial cell membrane glycoprotein and is detected in plasma and serum after endothelial injury. In our study comprising 311 patients with systemic lupus erythematosus (SLE) clinical and laboratory associations of elevated thrombomodulin serum concentrations were examined. Elevated thrombomodulin concentrations were detected in 7.1% of the SLE patients and were associated with nephritis including the laboratory parameters proteinuria and erythrocyte casts, vasculitis and neurological involvement of the central nervous system. These correlations remained significant after consideration of the influence of renal function. In SLE, the serum thrombomodulin concentration may become a marker to monitor damage of endothelial cells and involvement of the central nervous system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 26 May 1999 / Accepted: 16 June 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Witte, T., Hartung, K., Sachse, C. et al. Thrombomodulin in systemic lupus erythematosus: association with clinical and laboratory parameters. Rheumatology International 19, 15–18 (1999). https://doi.org/10.1007/s002960050092

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002960050092

Navigation